Open Access

Sub-acute administration of (S)-dimethyl 2-(3-(phenyltellanyl) propanamido) succinate induces toxicity and oxidative stress in mice: unexpected effects of N-acetylcysteine

  • Daiane F Meinerz1,
  • Bruna Comparsi1,
  • Josiane Allebrandt1,
  • Douglas Oscar Ceolin Mariano1,
  • Danúbia B dos Santos3,
  • Ana Paula Pegoraro Zemolin2,
  • Marcelo Farina3,
  • Luiz Alcir Dafre3,
  • João B T Rocha1,
  • Thaís Posser1, 2 and
  • Jeferson L Franco1, 2Email author

DOI: 10.1186/2193-1801-2-182

Received: 30 November 2012

Accepted: 16 April 2013

Published: 24 April 2013


The organic tellurium compound (S)-dimethyl 2-(3-(phenyltellanyl) propanamide) succinate (TeAsp) exhibits thiol-peroxidase activity that could potentially offer protection against oxidative stress. However, data from the literature show that tellurium is a toxic agent to rodents. In order to mitigate such toxicity, N-acetylcysteine (NAC) was administered in parallel with TeAsp during 10 days. Mice were separated into four groups receiving daily injections of (A) vehicle (PBS 2.5 ml/kg, i.p. and DMSO 1 ml/kg, s.c.), (B) NAC (100 mg/kg, i.p. and DMSO s.c.), (C) PBS i.p. and TeAsp (92.5 μmol/kg, s.c), or (D) NAC plus TeAsp. TeAsp treatment started on the fourth day. Vehicle or NAC-treated animals showed an increase in body weight whereas TeAsp caused a significant reduction. Contrary to expected, NAC co-administration potentiated the toxic effect of TeAsp, causing a decrease in body weight. Vehicle, NAC or TeAsp did not affect the exploratory and motor activity in the open-field test at the end of the treatment, while the combination of NAC and TeAsp produced a significant decrease in these parameters. No DNA damage or alterations in cell viability were observed in leukocytes of treated animals. Treatments produced no or minor effects on the activities of antioxidant enzymes catalase, glutathione peroxidase and glutathione reductase, whereas the activity of the thioredoxin reductase was decreased in the brain and increased the liver of the animals in the groups receiving TeAsp or TeAsp plus NAC. In conclusion, the toxicity of TeAsp was potentiated by NAC and oxidative stress appears to play a central role in this process.


Elemental tellurium (Te) is a rare trace element that is widely used in the manufacture of ceramics, glass, semiconductors, and metals (Ogra et al. 2008). Despite the growing use of organotellurium compounds in chemistry and biochemistry and the consequent increase in the risk of occupational and environmental exposure to these substances, data about their toxicity are scarce in the literature. In fact, these compounds have been shown to be promising and useful alternatives for numerous synthetic operations in organic synthesis (Petragnani 1994; Comasseto and Gariani 2009). Previous studies demonstrated that organotellurium compounds are potentially toxic and lethal to rodents at low doses (Meotti et al. 2003; Savegnago et al. 2006) Indeed, tellurides can cause cytotoxicity (Sailer et al. 2004), hepatotoxicity (Meotti et al. 2003), neurotoxicity (Nogueira et al. 2001; Nogueira et al. 2002), teratogenicity (Stangherlin et al. 2005) and genotoxicity (Santos et al. 2009a, b). Moreover, these compounds can inhibit sulfhydryl-containing enzymes, such as the Na+/K+-ATPase (Borges et al. 2005), the δ-aminolevulinic acid dehydratase (Maciel et al. 2000; Nogueira et al. 2003) and the squaleno monooxigenase (Laden and Porter 2001).

The mechanisms of toxicity by organotellurium compounds may be related to the oxidation of thiol groups of important biomolecules (Nogueira et al. 2004), the replacement of selenium in selenoproteins (such as thioredoxin reductase) (Engman et al. 2000), and the capacity of Te compounds to induce the formation of reactive oxygen species (ROS) (Chen et al. 2001; Funchal et al. 2011; de Andrade et al. 2010). On the other hand, pharmacological and/or antioxidants properties of tellurium compounds have also been reported in the literature (Ávila et al. 2011; Avila et al. 2012), including antitumor and chemoprotective effects (Engman et al. 2000; Cunha et al. 2005), and glutathione peroxidase (GPx) like activity (Engman et al. 1994). The existence of toxic and beneficial effects of tellurium compounds brings out the need for further research on their toxicological and pharmacological mechanisms of action.

The compound studied on the present work, (S)-dimethyl 2-(3-(phenyltellanyl) propanamido) succinate (TeAsp), is a new telluroamino acid derivative of aspartic acid that was found to be the most potent mimetic of GPx among 20 newly synthesized derivatives (Braga et al. 2009; Alberto et al. 2009) presenting antioxidant properties in vitro. However, when administered to rodents this compound showed potent genotoxic and mutagenic actions (Meinerz et al. 2011).

In order to elucidate the mechanisms mediating the biological effects of TeAsp, the present study aimed to investigate putative mechanisms underlying the toxicity of TeAsp in vivo. We assessed behavioral and oxidative stress parameters in mice, including the modulation of antioxidant enzymatic defense systems by TeAsp in different tissues. We also evaluated the potential protective effect of N-acetylcysteine (NAC), a thiol-containing antioxidant that is largely used to mitigate the effects of oxidative stress-causing agents (Flora et al. 2004) due to its ability to stimulate glutathione (GSH) synthesis.

Materials and methods


The chemical structure of TeAsp is shown in Figure 1. This compound was synthesized by the method previously described by Braga et al. (2009). TeAsp solutions were prepared in dimethyl sulfoxide (DMSO). All reagents used were purchased from Sigma (São Paulo, Brazil).
Figure 1

The chemical structure of ( S )-dimethyl 2-(3-(phenyltellanyl) propanamido) succinate (TeAsp).


Swiss adult male mice (45-days old), weighing 30–40 g, were used in the experiments. All mice were obtained from and maintained in the animal facilities of UFSM. Mice (5 per group) were kept in separate cages on 12-hour light/dark cycle, controlled temperature (22±3°C) and ad libitum access to food and water. The animals were used according to the guidelines of the institutional board for animal care and use (CEUA) of the Federal University of Santa Maria, Brazil (23081.002435/2007-16).

Exposure (animals treatment)

Mice were separated into four groups, with 5 animals each, receiving daily injections of: (A) vehicles of NAC and TeAsp respectively (PBS 2.5 ml/kg, i.p. plus DMSO 1 ml/kg (0.1%), s.c.); (B) NAC (100 mg/kg, i.p.) plus DMSO s.c.); (C) PBS i.p. plus TeAsp (92.5 μmol/kg, s.c.); or (D) NAC, i.p plus TeAsp, s.c. Treatment with TeAsp started just after the third day of NAC administration, using a dose equivalent to 50% of the previously described LD50 (185 μmol/kg) (Meinerz et al. 2011).

The animals were weighted daily and monitored for the appearance of signs of toxicity, such as exhalation of garlic odor, partial or total paralysis of lower limbs, diarrhea, tremors, hair loss, and weight loss. No signs of toxicity were apparent throughout the period of treatment. Behavioral evaluation was performed 24 hours after the end of the treatment.

Open field test

One day after the last injection the animals were acclimated to the experimental room for at least 2 hours prior to the beginning of the open field test. Open field tests were carried out in soundproof room without any human interference, as described elsewhere (Kim et al. 2000).

Antioxidant enzymes assays and protein determination

On the 11th day, following the behavior evaluation, the animals were anesthetized with ethyl ether and blood samples were collected by heart puncture for leukocytes viability and comet assay. The mice were then euthanized; the brain and liver were dissected, weighted, homogenized in a Potter- Elvehjem tissue homogenizer with 50 mM Tris–HCl buffer, pH 7.4 and centrifuged at 4000 × g for 10 min at 4°C. The low speed supernatant (S1) was collected and kept on ice until used for the enzyme assays.

The activities of the antioxidant enzymes catalase (CAT) (Aebi 1984), GPx (Wendel 1981), glutathione reductase (GR) (Carlberg and Mannervik 1985) and thioredoxin reductase (TrxR) (Holmgren and Björnstedt 1995) were determined in the S1 fraction of mice brain and liver as described elsewhere.

Protein concentration was determined by the method of Lowry et al. (1951), using bovine serum albumin as the standard.

Leukocyte DNA damage and viability

Leukocytes were isolated as describes in (Santos et al. 2009a) and the cell density was adjusted to 2 × 106 leukocytes/ml by dilution with HBSS/heparin. The percentage of viable leukocytes was determined using the Trypan blue exclusion method counting on a hemocytometer (Mischell and Shiingi 1980).

The comet assay was carried out following previously published procedures (Santos et al. 2009a). The slides were analyzed by at least two observers blinded to the experiment. One hundred cells per sample were randomly selected and visually scored based on tail intensity into five classes ranging from 0 (undamaged) to 4 (maximally damaged). The damage index (DI) is based on the length of migration and on the amount of DNA in the tail was calculated as follows:
DI = n 1 + 2 n 2 + 3 n 3 + 4 n 4

where, n1 represents the number of cells with level 1 of damage; n2, number of cells with level 2 of damage; n3, number of cells with level 3 of damage; n4, number of cells with level 4 of damage.

Statistical analysis

Data were analyzed using one or two way analysis of variance (ANOVA) followed by Newman-Keuls or Bonferroni post hoc test when appropriate. Differences were considered significant when p<0.05.


Body weight gain

No mortality occurred after repeated administration of NAC and/or TeAsp to mice. As expected, the animals’ body weight gains increased (17%) with time (Figure 2). Treatment with TeAsp for seven days (days 4–10) caused a significant decrease in body weight gain already in the fourth day after the first administration (day 7), producing a continuous decrease until the end of the experiment, when animals weighted 6% less. Animals treated with NAC followed the same trend. Compared to control (vehicle-treated) animals at the end of the treatment TeAsp-treated mice presented an average 23% lower body weight. Instead of decreasing TeAsp toxicity, NAC potentiated its effect on weight loss, producing an additional 8% decrease in body weight (14% total).
Figure 2

Effect of (S)dimethyl 2-(3 (phenyltellanyl) propanamido) succinate (TeAsp) on the body weight gain of adult mice. Data are reported as percentage ± S.E.M. of 5 animals per group. Two way ANOVA followed by Bonferroni posttest. * (p<0.05), ** (p<0.01) or *** (p<0.001) represent significant differences from PBS/DMSO and ## (p<0.01) or ### (p<0.001) means significant differences from NAC/DMSO group.

Open field test

To assess whether the treatment with NAC and/or compound could cause changes in exploratory or locomotor behavior of animals, the mice were exposed to open field test and we observed that treatment with vehicle (PBS or DMSO), NAC or TeAsp did not cause any alterations in this behavior. However, when the mice were treated with TeAsp plus NAC, 60% decrease in locomotion and 35% decrease in exploratory behavior were observed (Figure 3).
Figure 3

Effects of (S)dimethyl 2-(3 (phenyltellanyl) propanamido) succinate (TeAsp) on open field test, number of rearings (A) and number of crossing (B) from adult mice. Data are reported as mean ± S.E.M. of 5 animals per group. One way ANOVA followed by Newman-Keuls Multiple Comparison Test. * (p<0.05) represents significant differences from PBS/DMSO group; # (p<0.05) and ## (p<0.01) represents significant differences from NAC/DMSO group and + (p<0.05) and +++ (p<0.001) represents significant difference from PBS/TeAsp.

Antioxidant enzymes activity

Considering that the compound caused alterations on weigh gain and behavior of the animals exposed, we carried out the antioxidant enzymes activity to determine if the toxicity could be related to oxidative stress in brain and liver.

Brain and liver CAT and GPx (Table 1) activities were not altered by the treatments. Liver GR activity (Table 1) was elevated only in mice treated with TeAsp plus NAC.
Table 1

Effect of ( S )-dimethyl 2-(3-(phenyltellanyl) propanamido) succinate (TeAsp) on the activity of the antioxidant enzymes Catalase, Glutathione Peroxidase (GPx) and Glutathione Reductase (GR) from adult mice brain and liver


Catalase activitya

GPx activityb

GR activityb









0.55 ± 0.04

4.44 ± 0.7

8.12 ± 0.6

93.0 ± 3.6

21.05 ± 0.1

38.6 ± 4.3


0.66 ± 0.1

5.19 ± 0.8

9.09 ± 0.6

105.1 ± 9.2

25.58 ± 2.55

45.6 ± 3.9


0.57 ± 0.05

3.72 ± 0.5

8.47 ± 0.4

91.8 ± 2.5

18.94 ± 0.65

44.8 ± 5.1


0.64 ± 0.1

3.38 ± 0.32

7.06 ± 0.65

97.1 ± 7.2


62.5 ± 5.9*

Results are mean ± S.E.M., n= 5 per group. One way ANOVA followed by Newman-Keuls Multiple Comparison Test.

*Values significantly different from the PBS/DMSO group with p<0.05.

aCatalase activity is expressed as μmol H2O2/min/mg of protein.

bGPx activity and GR activity are expressed as nmol NADPH/min/mg of protein.

The brain TrxR activity (Figure 4) was significantly decreased following the treatment with TeAsp (p<0.001) or TeAsp plus NAC (p<0.01). In contrast, the hepatic TrxR activity increased following the treatment with either TeAsp alone (p<0.05) or in combination with NAC (p<0.001).
Figure 4

Effects of (S)dimethyl 2-(3 (phenyltellanyl) propanamido) succinate (TeAsp) on TrxR activity in brain (A) and liver (B) of mice. The results are expressed as TNB/min/mg of protein and data are reported as mean ± S.E.M. of 5 animals per group. One way ANOVA followed by Newman-Keuls Multiple Comparison Test. * (p<0.05), ** (p<0.01) or *** (p<0.001) represents significant differences from PBS/DMSO group; ## (p<0.01) or ### (p<0.001) represents significant differences from NAC/DMSO group.

Cell viability and DNA damage

Another sign of toxicity is related to damage to DNA and cytoxicity that in this study were evaluated by comet assay and cell viability. In the mice treated in this study the administration of TeAsp alone or in combination with NAC did not cause cytotoxicity or genotoxicity to mice leukocytes (Table 2).
Table 2

Cell viability and DNA damage in leukocytes of TeAsp- treated mice


Viability (%)














Results are mean ± S.E.M., n= 5 per group. One way ANOVA followed by Newman-Keuls Multiple Comparison Test. Viability means the percentage of Trypan blue-negative cells.

D.I.: Damage index was calculated as follows: DI = n1 + 2n2 + 3n3 + 4n4.

Where, n1 represents the number of cells with level 1 of damage; n2, number of cells with level 2 of damage; n3, number of cells with level 3 of damage; n4, number of cells with level 4 of damage.


In the present study, we show that the administration of TeAsp for 7 days to mice induces significant changes on body weight, locomotor and exploratory behavior, as well as on the antioxidant enzymatic system. Previous studies have shown the antioxidant properties of Te compounds (Ávila et al. 2007; Ávila et al. 2010; Avila et al. 2012). Two previous studies investigated the effects TeAsp in vitro (Braga et al. 2009; Meinerz et al. 2011). However, even though presenting antioxidant properties in vitro, organotellurium compounds have been found to be toxic in vivo and in vitro (Sailer et al. 2004; Santos et al. 2009a, b; Funchal et al. 2011; Schiar et al. 2009; Pessoto et al. 2007). In a previous study, we found that TeAsp causes a significant mutagenic and genotoxic effect in mice when the doses administered are close to the LD50 (Meinerz et al. 2011). However, the mechanisms of TeAsp toxicity are still unclear. In the presented study, mice treated with TeAsp exhibited overt signs of toxicity, which included a remarkable weight loss and garlic odor exhalation. In fact, garlic odor exhalation is considered a hallmark of intoxication caused by tellurium compounds (Taylor 1996). Considering the chemistry of tellurium compounds, the oxidation of Te(II) to Te(IV) and its interaction with nucleophilic centers of biomolecules is thought to underlie the toxicity of tellurium containing organic moieties. In this context, considering that tellurium compounds can be toxic due to depletion of cellular thiol groups (Deuticke et al. 1992), we attempted to reduce TeAsp toxicity by using the thiol donor (NAC). There is abundant evidence regarding the use of NAC as an antioxidant. It is a thiol-containing molecule that has been widely used for promoting GSH synthesis (Moldeus et al. 1986; Sathish et al. 2011; Atkuri et al. 2007). The rationale for the use of NAC in the present study was that it would be able to protect against the deleterious effects of TeAsp. However, instead of protecting, we found that NAC potentiated the toxic effects of TeAsp.

Regarding the open-field behavior results, mice treated with TeAsp alone showed no difference compared to control animals. However, the mice treated with NAC plus TeAsp showed a significant decrease in locomotor activity and exploratory behavior. These results corroborate data from the literature that show that Te compounds usually exert toxic effects on the nervous system (Nogueira et al. 2002; Pinton et al. 2010). However, in the case of TeAsp, the toxic effect was observed only after concomitant treatment with NAC. We suggest that the thiol group of NAC could interact with the tellurium atom of TeAsp either by changing it to a more toxic compound or by forming a complex that could cause greater toxicity to cells of target organs. In fact, it was possible to observe an interaction between TeAsp and NAC by a spectroscopic approach using their absorption spectra between 200–800 nm. In that experiment, NAC shifted the absorption spectra of TeAsp between 320–380 nm (data not shown). That indicates that NAC reacts with TeAsp, a fact that might be occurring in vivo as well.

Antioxidant enzymes are considered to be a primary defense that prevents macromolecules from oxidative damage (Subramanian and James 2010). Alterations in enzymatic antioxidant systems are frequently used as markers of toxicity induced by a variety of organic compounds, heavy metals, aging and disease (Liu et al. 2004; Franco et al. 2009; Ling et al. 2011). The brain is especially susceptible to oxidative stress due to its elevated oxygen consumption (Noseworthy and Bray 1998). Accordingly, brain cells are equipped with an efficient antioxidant machinery, including the glutathione and thioredoxin systems, to dispose of the reactive species generated by high rates of aerobic metabolism (Dringen et al. 2005; Kudin et al. 2012). In this study, TeAsp did not alter the activity of most of the brain antioxidant enzymes tested (GR, GPx or CAT), even when concomitantly administered with NAC. The activity of the brain TrxR was, on the other hand, decreased following the treatment with TeAsp alone. According to previously published data, Te compounds can inhibit TrxR and cause cytotoxicity in vitro, probably due to the high affinity of Te compounds for the thiol and selenol groups found in TrxR (Engman et al. 2000; Engman et al. 2003). Inhibition of the Trx system is likely to further increase the brain’s susceptibility to oxidative stress. Recent studies have demonstrated the crucial role of this antioxidant system in performing peroxide detoxification in the brain (Kudin et al. 2012). In line with this evidence, the inhibition of brain TrxR by TeAsp observed in this study might be, at least in part, considered a potential mechanism of neurotoxicity induced by this organotelluride.

Comparable to what we observed in the brain, liver catalase was also unchanged after the mice were exposed to TeAsp. However, an opposite effect was observed for GR and TrxR activities in liver. Previous reports have shown that acute exposure to oxidants frequently increases the activity of antioxidant enzymes as an adaptive response which, consequently, reduces the damage (Hilbert and Mohsenin 1996). GR and TrxR are known to be involved in the regeneration of GSH and thioredoxin, respectively (Meister and Anderson 1983; Arnér and Holmgren 2000). Our data showed that these enzymes were increased in the liver of treated animals. This result could indicate an up-regulation of the cellular thiol regenerating systems. In this way, the thiol oxidizing effect of TeAsp, as well as other organotellurides (Meinerz et al. 2011), could trigger a compensatory response to TeAsp-induced hepatic GSH and Trx(SH)2 oxidation.

The NF-E2-related factor 2 (Nrf2) is thought to be a pivotal regulator of the ARE-driven cellular defense against oxidative stress and its regulation appears to be cell specific (Lee et al. 2005). This transcription factor binds to the “antioxidant responsive element” – ARE (Nrf2-ARE pathway) and has been shown to regulate the expression of several antioxidant proteins such as glutathione-S-transferase, GPX, GR, SOD, CAT and the thioredoxin system (Tanito et al. 2007; Hur and Gray 2011; Schülke et al. 2012). However, the positive or negative balance of Nrf2-ARE pathway activation depends on the combination of numerous factors. Several nuclear factors are shown to bind ARE, including c-Jun, c-Fos, Nrf1, Nrf2, MafG, MafK, among others (Jaiswal 2004; Dhakshinamoorthy et al. 2005). Moreover, the downregulation of the Nrf2-ARE pathway is not well understood. In this context, Nrf2 can be inactivated by Kelch-like ECH-associated protein 1 (Keap1) in the cytoplasm (Wang and Zhang 2009). In that same context, the Bach1 transcription factor has been shown to induce negative regulation of the Nrf2-ARE driven antioxidant response (Dhakshinamoorthy et al. 2005). Taking it all into account, one could suppose that the opposing responses such as the observed in our study between brain and liver GR and TrxR may be related to alternative regulation of the ARE-driven protective pathway in different tissues.


Summarizing, contrary to the hypothesized, NAC did not protect against TeAsp-induced toxicity in mice. On the contrary, NAC exacerbated the general and behavioral toxicity elicited by TeAsp. Although not addressed in this study, we may speculate that the exacerbation of TeAsp toxicity by NAC may be associated with the formation of intermediate(s) with higher toxicity (for instance, diphenyl ditelluride) or to the release of Te from the organic moiety to generate a more toxic inorganic form (Te(IV)). Additional studies are necessary to determine the precise mechanisms of TeAsp toxicity and its interaction with NAC. The elucidation of such mechanisms would contribute to understanding the events mediating the therapeutic and toxic effects of Tellurium compounds.



Authors thanks for financial support by FAPERGS, FAPERGS-PRONEX, CNPq, FINEP, and also by the revision of the manuscript by Dr. Marcelo Reis.

Authors’ Affiliations

Departamento de Química, Centro de Ciências Naturais e Exatas, Universidade Federal de Santa Maria
Universidade Federal do Pampa
Departamento de Bioquímica, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina


  1. Aebi H: Catalase in vitro. Methods Enzymol 1984, 105: 121-126.View ArticleGoogle Scholar
  2. Alberto EE, Soares LC, Sudati JH, Borges AC, Rocha JBT, Braga AL: Efficient synthesis of modular amino acid derivatives containing selenium with pronounced GPx like activity. European J Org Chem 2009, 25: 4211-4214.View ArticleGoogle Scholar
  3. Arnér ESJ, Holmgren A: Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem 2000, 267: 6102-6109. 10.1046/j.1432-1327.2000.01701.xView ArticleGoogle Scholar
  4. Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA: N- Acetylcysteine—a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol 2007, 7: 355-359. 10.1016/j.coph.2007.04.005View ArticleGoogle Scholar
  5. Avila DS, Benedetto A, Au C, Manarin F, Erikson K, Soares FA, Rocha JB, Aschner M: Organotellurium and organoselenium compounds attenuate Mn-induced toxicity in C. elegans by preventing oxidative stress. Free Radic Biol Med 2012, 52: 1903-1910. 10.1016/j.freeradbiomed.2012.02.044View ArticleGoogle Scholar
  6. Ávila DS, Colle D, Gubert P, Palma AS, Puntel G, Manarin F, Noremberg S, Nascimento PC, Aschner M, Rocha JBT, Soares FAA: A possible neuroprotective action of a vinylic telluride against Mn-induced neurotoxicity. Toxicol Sci 2010, 115: 194-201. 10.1093/toxsci/kfq036View ArticleGoogle Scholar
  7. Ávila DS, Gubert P, Dalla Corte CL, Alves D, Nogueira CW, Rocha JBT, Soares FAA: A biochemical and toxicological study with diethyl 2-phenyl-2-tellurophenyl vinylphosphonate in a subchronic intraperitoneal treatment in mice. Life Sci 2007, 80: 1865-1872. 10.1016/j.lfs.2007.02.033View ArticleGoogle Scholar
  8. Ávila DS, Palma AS, Colle D, Scolari R, Manarin F, da Silveira AF, Nogueira CW, Rocha JBT, Soares FAA: Hepatoprotective activity of a vinylic telluride against acute exposure to acetaminophen. Eur J Pharmacol 2011, 661: 92-10. 10.1016/j.ejphar.2011.04.031View ArticleGoogle Scholar
  9. Borges VC, Rocha JBT, Nogueira CW: Effect of diphenyl diselenide, diphenyl ditelluride and ebselen on cerebral Na+K+ ATPase activity in rats. Toxicol 2005, 215: 191-197. 10.1016/j.tox.2005.07.002View ArticleGoogle Scholar
  10. Braga AL, Alberto EE, Soares LC, Rocha JBT, Sudati JH, Roos DH: Synthesis of telluroamino acid derivatives with remarkable GPx like activity. Org Biomol Chem 2009, 7: 43-45. 10.1039/b814990aView ArticleGoogle Scholar
  11. Carlberg I, Mannervik B: Glutathione reductase. Methods Enzymol 1985, 113: 484-490.View ArticleGoogle Scholar
  12. Chen F, Vallyathan V, Castranova V, Shi X: Cell apoptosis induced carcinogenic metals. Mol Cel Biochem 2001, 221: 183-188.View ArticleGoogle Scholar
  13. Comasseto JV, Gariani RA: Biotransformations on organic selenides and tellurides: synthetic applications. Tetrahedron 2009, 65: 8447-8459. 10.1016/j.tet.2009.06.121View ArticleGoogle Scholar
  14. Cunha LOR, Urano ME, Chagas JR, Almeida PC, Bincoletto C, Tersariol ILS, Comasseto JV: Tellurium-based cysteine protease inhibitors: evaluation of novel organotellurium (IV) compounds as inhibitors of human cathepsin B. Bioorg Med Chem Lett 2005, 15: 755-760. 10.1016/j.bmcl.2004.11.012View ArticleGoogle Scholar
  15. de Andrade RB, Gemelli T, Guerra RB, Funchal C, Wannmacher CM: Inhibition of creatine kinase activity by 3-butyl-1-phenyl-2-(phenyltelluro)oct-en 1-one in the cerebral cortex and cerebellum of young rats. J Appl Toxicol 2010, 30: 611-661. 10.1002/jat.1533View ArticleGoogle Scholar
  16. Deuticke B, Lutkemeier RK, Pose B: Tellurite- induced damage of the erythrocyte membrane. Manifestations and mechanisms. Biochem Biophys Acta 1992, 1109: 97-107. 10.1016/0005-2736(92)90192-OView ArticleGoogle Scholar
  17. Dhakshinamoorthy S, Jain AK, Bloom DA, Jaiswal AK: Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants. J Biol Chem 2005, 280: 16891-16900. 10.1074/jbc.M500166200View ArticleGoogle Scholar
  18. Dringen R, Pawlowski PG, Hirrlinger J: Peroxide detoxification by brain cells. J Neurosci Res 2005, 79: 157-165. 10.1002/jnr.20280View ArticleGoogle Scholar
  19. Engman L, Al-Maharik N, Mcnaughton M, Birmingham A, Powis G: Thioredoxin reductase and cancer cell growth inhibition by organotellurium antioxidants. Anticancer Drugs 2003, 14: 153-161. 10.1097/00001813-200302000-00009View ArticleGoogle Scholar
  20. Engman L, Kanda T, Gallegos A, Williams R, Powis G: Water soluble organotellurium compounds inhibit thioredoxin reductase and the growth of human cancer cells. Anti-Cancer Drug Des 2000, 15: 323-330.Google Scholar
  21. Engman L, Tunek A, Hallberg M, Hallberg A: Catalytic effects of glutathione peroxidase mimetics on the thiol reduction of cytochrome c. Chem Biol Interact 1994, 93: 129-137. 10.1016/0009-2797(94)90092-2View ArticleGoogle Scholar
  22. Flora SJS, Pande M, Kannan GM, Mehta A: Lead induced oxidative stress and its recovery following co-administration of melatonin or n-acetylcysteine during chelation with succimer in male rats. Cell Mol Biol 2004, 50: OL543-OL551.Google Scholar
  23. Franco JL, Posser T, Dunkley PR, Dickson PW, Mattos JJ, Martins R, Bainy AC, Marques MR, Dafre AL, Farina M: Methylmercury neurotoxicity is associated with inhibition of the antioxidant enzyme glutathione peroxidase. Free Radic Biol Med 2009, 47: 449-457. 10.1016/j.freeradbiomed.2009.05.013View ArticleGoogle Scholar
  24. Funchal C, de Andrade RB, Turcatel E: Acute treatment with the organochalcogen 3-butyl-1-phenyl-2 (phenyltelluro)oct-en-1-one produces behavioral changes and inhibition of creatine kinase activity in the brain of rats. Int J Dev Neurosci 2011, 29: 903-907. 10.1016/j.ijdevneu.2011.07.001View ArticleGoogle Scholar
  25. Hilbert J, Mohsenin V: Adaptation of lung antioxidants to cigarette smoking in humans. Chest 1996, 110: 916-920. 10.1378/chest.110.4.916View ArticleGoogle Scholar
  26. Holmgren A, Björnstedt M: Thioredoxin and thioredoxin reductase. Meth Enzymol 1995, 252: 199-208.View ArticleGoogle Scholar
  27. Hur W, Gray NS: Small molecule modulators of antioxidant response pathway. Curr Opin Chem Biol 2011, 15: 162-173. 10.1016/j.cbpa.2010.12.009View ArticleGoogle Scholar
  28. Jaiswal AK: Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med 2004, 36: 1199-1207. 10.1016/j.freeradbiomed.2004.02.074View ArticleGoogle Scholar
  29. Kim CY, Nakai K, Kasanuma Y, Satoh H: Comparison of neurobehavioral changes in three inbred strains of mice prenatally exposed to methylmercury. Neurotoxicol Teratol 2000, 22: 397-403. 10.1016/S0892-0362(99)00077-XView ArticleGoogle Scholar
  30. Kudin AP, Augustynek B, Lehmann AK, Kovács R, Kunz WS: The contribution of thioredoxin-2 reductase and glutathione peroxidase to H(2)O(2) detoxification of rat brain mitochondria. Biochim Biophys Acta 2012, 1817: 1901-1906. 10.1016/j.bbabio.2012.02.023View ArticleGoogle Scholar
  31. Laden BP, Porter TD: Inhibition oh human squalene monooxigenase by tellurium compounds: evidence of interaction with vicinal sulfhydryls. J Lipid Res 2001, 42: 235-240.Google Scholar
  32. Lee JM, Li J, Johnson DA, Stein TD, Kraft AD, Calkins MJ, Jakel RJ, Johnson JA: Nrf2, a multi-organ protector? FASEB J 2005, 19: 1061-1066. 10.1096/fj.04-2591hypView ArticleGoogle Scholar
  33. Ling X, Zhang Y, Lu Y, Huang H: Superoxide dismutase, catalase and acetylcholinesterase: biomarkers for the joint effects of cadmium, zinc and methyl parathion contamination in water. Environ Technol 2011, 32: 1463-1470. 10.1080/09593330.2010.539272View ArticleGoogle Scholar
  34. Liu H, Wang H, Shenvi S, Hagen TM, Liu RM: Glutathione metabolism during aging and in Alzheimer disease. Ann N Y Acad Sci 2004, 1019: 346-349. 10.1196/annals.1297.059View ArticleGoogle Scholar
  35. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951, 193: 265.Google Scholar
  36. Maciel EN, Bolzan RC, Braga AL, Rocha JB: Diphenyl diselenide and diphenyl ditelluride differentially affect delta-aminolevulinate dehydratase from liver, kidney, and brain of mice. J Biochem Mol Toxicol 2000, 14: 310-319. 10.1002/1099-0461(2000)14:6<310::AID-JBT3>3.0.CO;2-DView ArticleGoogle Scholar
  37. Meinerz DF, Sudati JH, dos Santos DB, Frediani A, Alberto EE, Allebrandt J, Franco JL, Barbosa NB, Aschner M, da Rocha JB: Evaluation of the biological effects of (S)-dimethyl 2-(3-(phenyltellanyl) propanamido) succinate, a new telluroamino acid derivative of aspartic acid. Arch Toxicol 2011, 85: 43-49. 10.1007/s00204-010-0555-3View ArticleGoogle Scholar
  38. Meister A, Anderson ME: Glutathione. Ann Rev Biochem 1983, 52: 711-760. 10.1146/ ArticleGoogle Scholar
  39. Meotti FC, Borges VC, Zeni JBT, Nogueira CW: Potential renal and hepatic toxicity of diphenyl diselenide, diphenyl ditelluride and ebselen for rats and mice. Toxicol Lett 2003, 143: 9-16. 10.1016/S0378-4274(03)00090-0View ArticleGoogle Scholar
  40. Mischell BB, Shiingi SM: Selected Methods in Cellular Immunology. New York: W.H.Freeman Company; 1980:1-469.Google Scholar
  41. Moldeus P, Cotgreave IA, Berggren M: Lung protection by a thiol-containing antioxidant: N-acetylcysteine. Respiration 1986, 50: 31-42.View ArticleGoogle Scholar
  42. Nogueira CW, Borges VC, Zeni G, Rocha JBT: Organochalcogens effects on d-aminolevulinate dehydratase activity from human erythrocytic cells in vitro. Toxicol 2003, 191: 169-178. 10.1016/S0300-483X(03)00250-6View ArticleGoogle Scholar
  43. Nogueira CW, Rotta LN, Perry ML, Souza DO, Rocha JBT: Diphenyl diselenide and diphenyl ditelluride affect the rat glutamatergic system in vitro and in vivo. Brain Res 2001, 906: 157-163. 10.1016/S0006-8993(01)02165-5View ArticleGoogle Scholar
  44. Nogueira CW, Rotta LN, Zeni G, Souza DO, Rocha JBT: Exposure to ebselen changes glutamate uptake and release by rat brain synaptossomes. Neurochem Res 2002, 27: 283-288. 10.1023/A:1014903127672View ArticleGoogle Scholar
  45. Nogueira CW, Zeni G, Rocha JBT: Organoselenium and organotellurium compounds: pharmacology and toxicology. Chem Rev 2004, 104: 6255-6286. 10.1021/cr0406559View ArticleGoogle Scholar
  46. Noseworthy MD, Bray TM: Effect of oxidative stress on brain damage detected by MRI and in vivo 31P-NMR. Free Radic Biol Med 1998, 24: 942-951. 10.1016/S0891-5849(97)00383-3View ArticleGoogle Scholar
  47. Ogra Y, Kobayashi R, Ishiwata K, Suzuki KT: Comparison of distribution and metabolism between tellurium and selenium in rats. J Inorg Biochem 2008, 102: 1507-1513. 10.1016/j.jinorgbio.2008.01.012View ArticleGoogle Scholar
  48. Pessoto FS, Faria PA, Cunha RLOR, Comasseto JV, Rodrigues T, Nantes IL: Organotellurane-promoted mitochondrial permeability transition concomitant with membrane lipid protection against oxidation. Chem Res Toxicol 2007, 20: 1453-1461. 10.1021/tx700092rView ArticleGoogle Scholar
  49. Petragnani N: Tellurium in organic synthesis. New York: Academic Press; 1994.Google Scholar
  50. Pinton S, Luchese C, Stangherlin EC, Roman SS, Nogueira CW: Diphenyl Ditelluride Induces Neurotoxicity and Impairment of Developmental Behavioral in Rat Pups. J Braz Chem Soc 2010, 21: 2130-2137. 10.1590/S0103-50532010001100015View ArticleGoogle Scholar
  51. Sailer BL, Liles N, Dickerson S, Sumners S, Chasteen TG: Organotellurium compound toxicity in a promyelocytic cell line compared to non-tellurium- containing organic analog. Toxicol In Vitro 2004, 18: 475-482. 10.1016/j.tiv.2003.11.001View ArticleGoogle Scholar
  52. Santos DB, Schiar VPP, Paixão MW, Meinerz DF, Nogueira CW, Aschner M, Rocha JBT, Barbosa NBV: Hemolytic and genotoxic evaluation of organochalcogens in human blood cells in vitro. Toxicol In Vitro 2009, 23: 1195-1204. 10.1016/j.tiv.2009.05.010View ArticleGoogle Scholar
  53. Santos DB, Schiar VPP, Ribeiro MCP, Schwab RS, Meinerz DF, Allebrandt J, Rocha JBT, Nogueira CW, Aschner M, Barbosa NBV: Genotoxicity of organoselenium compounds in human leukocytes in vitro. Mutat Res 2009, 676: 21-26. 10.1016/j.mrgentox.2009.03.006View ArticleGoogle Scholar
  54. Sathish P, Paramasivan V, Palani V, Sivanesan K: N-acetylcysteine attenuates dimethylnitrosamine induced oxidative stress in rats. Eur J Pharmacol 2011, 654: 181-186. 10.1016/j.ejphar.2010.10.080View ArticleGoogle Scholar
  55. Savegnago L, Borges VC, Alves D, Jesse C, Rocha JBT, Nogueira CW: Evaluation of antioxidant activity and potential toxicity of 1-buthyltelurenyl-2 methylthioheptene. Life Sci 2006, 79: 1546-1552. 10.1016/j.lfs.2006.04.018View ArticleGoogle Scholar
  56. Schiar VP, Dos Santos DB, Paixão MW, Nogueira CW, Rocha JB, Zeni G: Human erythrocyte hemolysis induced by selenium and tellurium compounds increased by GSH or glucose: a possible involvement of reactive oxygen species. Chem Biol Interact 2009, 177: 28-33. 10.1016/j.cbi.2008.10.007View ArticleGoogle Scholar
  57. Schülke S, Dreidax D, Malik A, Burmester T, Nevo E, Band M, Avivi A, Hankeln T: Living with stress: Regulation of antioxidant defense genes in the subterranean, hypoxia-tolerant mole rat, Spalax. Gene 2012, 500: 199-206. 10.1016/j.gene.2012.03.019View ArticleGoogle Scholar
  58. Stangherlin EC, Favero AM, Zeni G, Rocha JBT, Nogueira CW: Teratogenic vulnerability of Wistar rats to diphenyl ditelluride. Toxicol 2005, 2: 231-239.View ArticleGoogle Scholar
  59. Subramanian MV, James TJ: Age-related protective effect of deprenyl on changes in the levels of diagnostic marker enzymes and antioxidant defense enzymes activities in cerebellar tissue in Wistar rats. Cell Stress Chaperones 2010, 15: 743-751. 10.1007/s12192-010-0177-yView ArticleGoogle Scholar
  60. Tanito M, Agbaga MP, Anderson RE: Upregulation of thioredoxin system via Nrf2-antioxidant responsive element pathway in adaptive-retinal neuroprotection in vivo and in vitro. Free Radic Biol Med 2007, 42: 1838-1850. 10.1016/j.freeradbiomed.2007.03.018View ArticleGoogle Scholar
  61. Taylor A: Biochemistry of tellurium. Biol Trace Elem Res 1996, 55: 231-239. 10.1007/BF02785282View ArticleGoogle Scholar
  62. Wang X-J, Zhang DD: Ectodermal-neural cortex 1 down-regulates Nrf2 at the translational level. PLoS One 2009, 4: e5492. 10.1371/journal.pone.0005492lView ArticleGoogle Scholar
  63. Wendel : A Glutathione peroxidase. Methods Enzymol 1981, 77: 325-333.View ArticleGoogle Scholar


© Meinerz et al.; licensee Springer. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.